The increased proliferation and migration of airway smooth muscle cells (ASMCs) is a key process in the formation of airway remodeling in asthma. In this study, we focused on the expression of mircoRNA-18a (miR-18a) in airway remodeling in bronchial asthma and its related mechanisms. ASMCs are induced by platelet-derived growth factor BB (PDGF-BB) for in vitro airway remodeling. The expression of miR-18a in sputum of asthmatic patients and healthy volunteers was detected by qRT-PCR. The expression of miR-18a was over-expressed or interfered with in PDGF-BB-treated ASMCs. Cell proliferation, apoptosis and migration were detected by MTT, flow cytometry and Transwell, respectively; the expression of contractile phenotype marker proteins (SM-22?, ?-SM-actin, calponin) and key molecules of the phosphatidylinositol 3-kinase (PI3K)/AKT pathway (PI3K, p-PI3K, AKT and p-AKT) in ASMCs were detected by Western blot. The expression of miR-18a was down-regulated in the sputum and PDGF-BB-treated ASMCs of asthma patients. PDGF-BB could promote the proliferation and migration of ASMCs and inhibit their apoptosis; it could also promote the phenotypic transformation of ASMCs and activate the PI3K/AKT pathway. MiR-18a could inhibit the proliferation, migration ability and phenotypic transformation of ASMCs induced by PDGF-BB to a certain extent and alleviate the effect of PDGF-BB in supressing apoptosis, while miR-18a could inhibit the activation of the PI3K/AKT pathway. MiR-18a inhibits PDGF-BB-induced proliferation, migration and phenotypic conversion of ASMCs by inhibiting the PI3K/AKT pathway, thus attenuating airway remodeling in asthma.

Department of Pediatrics The 1st Affiliated Hospital Jinan University Guangzhou Guangdong 510630 China

Zobrazit více v PubMed

AMMIT AJ, PANETTIERI RJ. Airway smooth muscle cell hyperplasia: a therapeutic target in airway remodeling in asthma? Prog Cell Cycle Res. 2003;5:49–57. PubMed

BOULET LP. Airway remodeling in asthma: update on mechanisms and therapeutic approaches. Curr Opin Pulm Med. 2018;24:56–62. doi: 10.1097/MCP.0000000000000441. PubMed DOI

BRETHERTON R, BUGG D, OLSZEWSKI E, DAVIS J. Regulators of cardiac fibroblast cell state. Matrix Biol. 2020;91–92:117–135. doi: 10.1016/j.matbio.2020.04.002. PubMed DOI PMC

CAMPA CC, SILVA RL, MARGARIA JP, PIRALI T, MATTOS MS, KRAEMER LR, REIS DC, GROSA G, COPPERI F, DALMARCO EM, LIMA-JUNIOR R, APRILE S, SALA V, DAL BELLO F, PRADO DS, ALVES-FILHO JC, MEDANA C, CASSALI GD, TRON GC, TEIXEIRA MM, CIRAOLO E, RUSSO RC, HIRSCH E. Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis. Nat Commun. 2018;9:5232. doi: 10.1038/s41467-018-07698-6. PubMed DOI PMC

DAI Y, LI Y, CHENG R, GAO J, LI Y, LOU C. TRIM37 inhibits PDGF-BB-induced proliferation and migration of airway smooth muscle cells. Biomed Pharmacother. 2018;101:24–29. doi: 10.1016/j.biopha.2018.02.057. PubMed DOI

FEHRENBACH H, WAGNER C, WEGMANN M. Airway remodeling in asthma: what really matters. Cell Tissue Res. 2017a;367:551–569. doi: 10.1007/s00441-016-2566-8. PubMed DOI PMC

GUIDA G, RICCIO AM. Immune induction of airway remodeling. Semin Immunol. 2019;46:101346. doi: 10.1016/j.smim.2019.101346. PubMed DOI

HIROTA N, MARTIN JG. Mechanisms of airway remodeling. Chest. 2013;144:1026–1032. doi: 10.1378/chest.12-3073. PubMed DOI

INUI M, MARTELLO G, PICCOLO S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol. 2010;11:252–263. doi: 10.1038/nrm2868. PubMed DOI

KACZMAREK KA, CLIFFORD RL, KNOX AJ. Epigenetic Changes in Airway Smooth Muscle as a Driver of Airway Inflammation and Remodeling in Asthma. Chest. 2019;155:816–824. doi: 10.1016/j.chest.2018.10.038. PubMed DOI

KING-BIGGS MB. Asthma. Ann Intern Med. 2019;171:C49–C64. doi: 10.7326/AITC201910010. PubMed DOI

LIU Y, MIAO Y, GAO X, WANG YY, WANG H, ZHENG YW, ZHAO ZY. MicroRNA-200a Affects the Proliferation of Airway Smooth Muscle Cells and Airway Remodeling by Targeting FOXC1 via the PI3K/AKT Signaling Pathway in Ovalbumin-Induced Asthmatic Mice. Cell Physiol Biochem. 2018;50:2365–2389. doi: 10.1159/000495097. PubMed DOI

LOU L, TIAN M, CHANG J, LI F, ZHANG G. MiRNA-192-5p attenuates airway remodeling and autophagy in asthma by targeting MMP-16 and ATG7. Biomed Pharmacother. 2020;122:109692. doi: 10.1016/j.biopha.2019.109692. PubMed DOI

MICHALIK M, WOJCIK-PSZCZOLA K, PAW M, WNUK D, KOCZURKIEWICZ P, SANAK M, PEKALA E, MADEJA Z. Fibroblast-to-myofibroblast transition in bronchial asthma. Cell Mol Life Sci. 2018;75:3943–3961. doi: 10.1007/s00018-018-2899-4. PubMed DOI PMC

MUNAKATA M. Airway remodeling and airway smooth muscle in asthma. Allergol Int. 2006;55:235–243. doi: 10.2332/allergolint.55.235. PubMed DOI

PUA HH, ANSEL KM. MicroRNA regulation of allergic inflammation and asthma. Curr Opin Immunol. 2015;36:101–108. doi: 10.1016/j.coi.2015.07.006. PubMed DOI PMC

SAMITAS K, CARTER A, KARIYAWASAM HH, XANTHOU G. Upper and lower airway remodelling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: The one airway concept revisited. Allergy. 2018;73:993–1002. doi: 10.1111/all.13373. PubMed DOI

SHAO Y, CHONG L, LIN P, LI H, ZHU L, WU Q, LI C. MicroRNA-133a alleviates airway remodeling in asthtama through PI3K/AKT/mTOR signaling pathway by targeting IGF1R. J Cell Physiol. 2019;234:4068–4080. doi: 10.1002/jcp.27201. PubMed DOI

SUOJALEHTO H, LINDSTROM I, MAJURI ML, MITTS C, KARJALAINEN J, WOLFF H, ALENIUS H. Altered microRNA expression of nasal mucosa in long-term asthma and allergic rhinitis. Int Arch Allergy Immunol. 2014;163:168–178. doi: 10.1159/000358486. PubMed DOI

VISHNOI A, RANI S. MiRNA Biogenesis and Regulation of Diseases: An Overview. Methods Mol Biol. 2017;1509:1–10. doi: 10.1007/978-1-4939-6524-3_1. PubMed DOI

WRIGHT DB, TRIAN T, SIDDIQUI S, PASCOE CD, JOHNSON JR, DEKKERS BG, DAKSHINAMURTI S, BAGCHI R, BURGESS JK, KANABAR V, OJO OO. Phenotype modulation of airway smooth muscle in asthma. Pulm Pharmacol Ther. 2013;26:42–49. doi: 10.1016/j.pupt.2012.08.005. PubMed DOI

YANG H, LI W, ZHANG Y, LI M, GAO Y, LAO C, SHI B. Regulatory role of miR-18a to CCN2 by TGF-beta1 signaling pathway in pulmonary injury induced by nano-SiO2. Environ Sci Pollut Res Int. 2018;25:867–876. doi: 10.1007/s11356-017-0344-0. PubMed DOI

YE F, TIAN L, ZHOU Q, FENG D. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5. Gene. 2019;721:144093. doi: 10.1016/j.gene.2019.144093. PubMed DOI

YUAN J, TAN L, YIN Z, ZHU W, TAO K, WANG G, SHI W, GAO J. MIR17HG-miR-18a/19a axis, regulated by interferon regulatory factor-1, promotes gastric cancer metastasis via Wnt/beta-catenin signalling. Cell Death Dis. 2019;10:454. doi: 10.1038/s41419-019-1685-z. PubMed DOI PMC

ZHANG C, WANG J, MA X, WANG W, ZHAO B, CHEN Y, CHEN C, BIHL JC. ACE2-EPC-EXs protect ageing ECs against hypoxia/reoxygenation-induced injury through the miR-18a/Nox2/ROS pathway. J Cell Mol Med. 2018;22:1873–1882. doi: 10.1111/jcmm.13471. PubMed DOI PMC

ZHAO X, YU FQ, HUANG XJ, XU BY, LI YL, ZHAO XY, GUO HF, LUAN B. Azithromycin influences airway remodeling in asthma via the PI3K/Akt/MTOR/HIF-1alpha/VEGF pathway. J Biol Regul Homeost Agents. 2018;32:1079–1088. PubMed

Ellagic acid attenuates muscle atrophy in STZ-induced diabetic mice